Breaking News Instant updates and real-time market news.

GOOG

Alphabet

$1,021.57

-27.51 (-2.62%)

, GOOGL

Alphabet Class A

$1,026.55

-26.6 (-2.53%)

11:28
03/25/18
03/25
11:28
03/25/18
11:28

Waymo CEO says its tech would have safely handled Uber incident, Reuters reports

John Krafcik, CEO of Alphabet's autonomous driving unit Waymo, said that the company's technology would have safely handled the Uber's self-driving incident that killed a pedestrian, according to Reuters. Reference Link

GOOG

Alphabet

$1,021.57

-27.51 (-2.62%)

GOOGL

Alphabet Class A

$1,026.55

-26.6 (-2.53%)

  • 28

    Mar

  • 11

    Apr

GOOG Alphabet
$1,021.57

-27.51 (-2.62%)

03/20/18
MSCO
03/20/18
NO CHANGE
Target $230
MSCO
Overweight
Morgan Stanley answers 'top 4 investor questions' about Facebook
Morgan Stanley analyst Brian Nowak identified the top four questions he's heard from Facebook investors and outlined his answers in a new note. Addressing "What should Facebook do?", Nowak's take is that the company should become more assertive about the mistakes it has made and how it intends to fix them. On the question of "regulatory risk," he does believe the Cambridge Analytica news has increased Facebook's risk, which he contends only furthers the impetus to begin to take control of the public message, self-regulate and improve safeguards. On the question of "fundamental risk," Nowak said he does not see a fundamental risk to revenue or EPS as of now and he is not changing his FY18 and FY19 forecasts, though he adds that the "drumbeat of negative news and headlines" increases the risk that there is some user backlash and an "eventual" advertiser backlash. On the question of whether Facebook's multiple has bottomed, Nowak said "Yes, but this isn't new," as he noted that its multiple makes the stock cheaper than Alphabet (GOOGL), eBay (EBAY) and "many other assets" that are growing more slowly and/or don't have as much long-term monetization potential. Nowak maintains his Overweight rating and $230 price target on Facebook shares.
03/20/18
CLVD
03/20/18
NO CHANGE
CLVD
Facebook pricing/ROI continuing higher, Twitter feedback constructive, says Cleveland Research
Citing a recent research into the digital advertising channel, Cleveland Research analyst Kevin Rottinghaus says that Facebook (FB) pricing continues to increase, justified by a continued improvement in ROI, and the social media platform appears to be opening more inventory on Instagram and Messenger. Meanwhile, the analyst says Twitter (TWTR) continues to improve in ad technology, advertiser/partner engagement, traffic and users, and the company is seeing some signs that ad dollars are coming back into the platform. Snap, on the other hand, is still seeing limited ad dollars to the platform as ROI and ad tech lag, with app redesign receiving cautious feedback, he contends. The analyst also pointed out that Amazon (AMZN) is viewed as taking incremental dollars otherwise likely to paid search and Google (GOOG; GOOGL), while remaining aggressive in expanding ad tech and sales channels.
03/21/18
ARGS
03/21/18
NO CHANGE
Target $61
ARGS
Buy
Oracle's soft Q4 cloud revenue view spooked the market, says Argus
Argus analyst Joseph Bonner writes that while Oracle (ORCL) posted a beat on Q3 earnings and revenue, along with a "remarkable" margin expansion, investors were spooked by lower than expected outlook for cloud revenue growth in Q4. The analyst contends that the company's key task is conversion of its blue-chip customer base to the cloud, as cloud computing becomes a standard in the next 3-5 years. Bonner adds that Oracle is also competing with "deep-pocketed" technology giants - Amazon (AMZN) Web Services, Microsoft's (MSFT) Azure, and Google (GOOG). The analyst remains positive on Oracle's prospects with a Buy rating and a $61 price target, pointing to the company's strong dividend growth, share buyback program, and below-peer valuation metrics.
03/22/18
LEHM
03/22/18
NO CHANGE
LEHM
Facebook, Twitter MAUs could drop on European regulation, says Barclays
Barclays analyst Ross Sandler says his recent checks indicate Europe's General Data Protection Regulation could be "slightly more problematic than Facebook (FB) implied in recent commentary." The analyst sees risk that reported monthly active users could drop off for Facebook and Twitter (TWTR) starting in late Q2. He adds, however, that daily active users are "far more important and less of a GDPR concern for the social networks." Daily users may also drop off a bit, Sandler adds. The analyst sees less of impact on ad revenue. Further, his checks suggest that most companies using cookies and tags for digital marketing should be relatively unchanged as most publishers have been using GDPR compliant notifications for months ahead of the May mandate. Beyond GDPR, Sandler thinks ePrivacy regulation, slated for 2020 and beyond, may be even more problematic for the social media group, and "accrue more control" to Google (GOOG, GOOGL) and Apple (AAPL).
GOOGL Alphabet Class A
$1,026.55

-26.6 (-2.53%)

03/19/18
JPMS
03/19/18
NO CHANGE
Target $340
JPMS
Overweight
Broadcom shipping volumes of Google's TPU2 AI chipset, says JPMorgan
JPMorgan analyst Harlan Sur believes Broadcom (AVGO) has started shipping production volumes of Google's (GOOG, GOOGL) TPU2 AI chipset to Google's datacenters and that 2018 will be the year that artificial intelligence starts to become a bigger part of Broadcom's wired business. He estimates the company's Application-specific Integrated Circuits revenue in the artificial intelligence/deep learning segment, with customers that include Google, Fujitsu and Intel (INTC), can reach $1B-$2B by 2020, from less than $100M today. The ASIC opportunity "represents another growth/diversification vector for Broadcom," Sur tells investors in a research note. He reiterates an Overweight rating on the shares with a $340 price target.

TODAY'S FREE FLY STORIES

KEG

Key Energy

$8.25

0.02 (0.24%)

06:10
11/20/18
11/20
06:10
11/20/18
06:10
Downgrade
Key Energy rating change  »

Key Energy downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOW

Lowe's

$91.34

-1.95 (-2.09%)

06:09
11/20/18
11/20
06:09
11/20/18
06:09
Hot Stocks
Lowe's sees 'positive trends' in FY19 »

Lowe's CEO Marvin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

STXB

Spirit of Texas Bancshares

$19.23

-0.66 (-3.32%)

06:08
11/20/18
11/20
06:08
11/20/18
06:08
Initiation
Spirit of Texas Bancshares initiated  »

Spirit of Texas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOW

Lowe's

$91.34

-1.95 (-2.09%)

06:07
11/20/18
11/20
06:07
11/20/18
06:07
Hot Stocks
Lowe's to exit Mexico retail operations, exploring strategic alternatives »

Management has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

STKS

One Group Hospitality

$2.77

-0.18 (-6.10%)

06:06
11/20/18
11/20
06:06
11/20/18
06:06
Initiation
One Group Hospitality initiated  »

One Group Hospitality…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

LOW

Lowe's

$91.34

-1.95 (-2.09%)

06:04
11/20/18
11/20
06:04
11/20/18
06:04
Earnings
Lowe's sees FY18 adj. EPS $5.08-$5.13, consensus $5.15 »

Sees FY18 revenue up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

CDNS

Cadence Design

$42.78

-2.98 (-6.51%)

, SNPS

Synopsys

$85.72

-4.37 (-4.85%)

06:04
11/20/18
11/20
06:04
11/20/18
06:04
Initiation
Cadence Design, Synopsys initiated  »

Cadence Design initiated…

CDNS

Cadence Design

$42.78

-2.98 (-6.51%)

SNPS

Synopsys

$85.72

-4.37 (-4.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 04

    Dec

  • 05

    Dec

  • 13

    Dec

  • 12

    Mar

KW

Kennedy Wilson

$18.63

-0.2 (-1.06%)

06:03
11/20/18
11/20
06:03
11/20/18
06:03
Hot Stocks
Kennedy Wilson signs two lease deals in Europe with WeWork and ASOS »

Kennedy Wilson has signed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOW

Lowe's

$91.34

-1.95 (-2.09%)

06:02
11/20/18
11/20
06:02
11/20/18
06:02
Earnings
Lowe's reports Q3 adj. EPS $1.04, consensus 98c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

SNPS

Synopsys

$85.72

-4.37 (-4.85%)

06:02
11/20/18
11/20
06:02
11/20/18
06:02
Initiation
Synopsys initiated  »

Synopsys initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 13

    Dec

CYAD

Celyad

$26.97

(0.00%)

06:00
11/20/18
11/20
06:00
11/20/18
06:00
Conference/Events
Celyad management to meet with William Blair »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 22

    Nov

  • 27

    Nov

  • 01

    Dec

  • 03

    Dec

  • 10

    Dec

CSII

Cardiovascular Systems

$28.79

-1.7 (-5.58%)

05:59
11/20/18
11/20
05:59
11/20/18
05:59
Conference/Events
Cardiovascular Systems management to meet with William Blair »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

ACAD

Acadia

$18.14

-0.78 (-4.12%)

, KKR

KKR

$21.08

-0.75 (-3.44%)

05:58
11/20/18
11/20
05:58
11/20/18
05:58
Periodicals
KKR still in talks to buy Acadia Healthcare, NY Post reports »

KKR (KKR) is still deep…

ACAD

Acadia

$18.14

-0.78 (-4.12%)

KKR

KKR

$21.08

-0.75 (-3.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDGL

Madrigal Pharmaceuticals

$120.49

-8.98 (-6.94%)

05:57
11/20/18
11/20
05:57
11/20/18
05:57
Conference/Events
Madrigal Pharmaceuticals management to meet with JMP Securities »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

MCD

McDonald's

$186.69

-0.96 (-0.51%)

05:54
11/20/18
11/20
05:54
11/20/18
05:54
Conference/Events
McDonald's management to meet with MKM Partners »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

KEX

Kirby

$74.67

-1.225 (-1.61%)

05:51
11/20/18
11/20
05:51
11/20/18
05:51
Conference/Events
Kirby management to meet with Seaport Global »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

EFX

Equifax

$101.75

0.84 (0.83%)

05:50
11/20/18
11/20
05:50
11/20/18
05:50
Periodicals
Equifax to cut 33 jobs from Garden City office, NY Post reports »

Equifax is planning to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

IOVA

Iovance Biotherapeutics

$8.90

-0.68 (-7.10%)

05:47
11/20/18
11/20
05:47
11/20/18
05:47
Conference/Events
Iovance Biotherapeutics management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

FLWS

1-800-Flowers.com

$12.55

-0.2 (-1.57%)

05:45
11/20/18
11/20
05:45
11/20/18
05:45
Conference/Events
1-800-Flowers.com management to meet with Craig Hallum »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

BSX

Boston Scientific

$35.29

-1.93 (-5.19%)

05:45
11/20/18
11/20
05:45
11/20/18
05:45
Conference/Events
Boston Scientific to host investor update conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 27

    Nov

DHR

Danaher

$101.29

-1.95 (-1.89%)

05:45
11/20/18
11/20
05:45
11/20/18
05:45
Conference/Events
Danaher management to meet with Morgan Stanley »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 30

    Nov

  • 13

    Dec

ARRS

Arris

$30.67

0.01 (0.03%)

05:44
11/20/18
11/20
05:44
11/20/18
05:44
Conference/Events
Arris management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 13

    Dec

COO

Cooper Companies

$256.76

-8.32 (-3.14%)

05:43
11/20/18
11/20
05:43
11/20/18
05:43
Recommendations
Cooper Companies analyst commentary  »

Cooper fundamentals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

  • 06

    Dec

AMP

Ameriprise

$125.95

-0.645 (-0.51%)

05:43
11/20/18
11/20
05:43
11/20/18
05:43
Conference/Events
Ameriprise management to meet with William Blair »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

EPAM

Epam Systems

$120.96

-4.25 (-3.39%)

05:39
11/20/18
11/20
05:39
11/20/18
05:39
Initiation
Epam Systems initiated  »

Epam Systems initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.